Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years

The high disease burden of influenza in elderly and chronically ill adults may be due to the suboptimal effectiveness and mismatch of the conventional trivalent influenza vaccine (TIV). This study evaluated the cost-effectiveness of quadrivalent (QIV), adjuvanted trivalent (ATIV), and high-dose quad...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Min Joo, Shin, Gyeongseon, Kang, Daewon, Lim, Jae-Ok, Kim, Yun-Kyung, Choi, Won Suk, Yun, Jae-Won, Noh, Ji Yun, Song, Joon Young, Kim, Woo Joo, Choi, Sang-Eun, Cheong, Hee Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955502/
https://www.ncbi.nlm.nih.gov/pubmed/35335077
http://dx.doi.org/10.3390/vaccines10030445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955502/
https://www.ncbi.nlm.nih.gov/pubmed/35335077
http://dx.doi.org/10.3390/vaccines10030445

Ejemplares similares